U.S. Securities and Exchange Commission

                            Washington, D.C. 20549


                                 FORM 10-QSB

 (Mark One)
  [ X ]     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
            EXCHANGE ACT OF 1934

            For the quarterly period ended March 31, 2003

  [   ]     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
            EXCHANGE ACT OF 1934

            For the transition period from                    to

            Commission file number: 000-26740

                         AMERICAN HEALTHCHOICE, INC.
      (Exact name of small business issuer as specified in its charter)

                 New York                                    11-2931252
      (State or other jurisdiction of                     (I.R.S. Employer
      incorporation or organization)                    Identification No.)

      2221 Justin Road, Suite 119-154, Flower Mound, TX        75028
      (Address of principal executive offices)               (Zip Code)

                                (972) 751-1900
                         (Issuer's telephone number)

      Check whether the issuer (1) filed all reports required to be filed by
 Section 13 or 15(d) of the Exchange Act  during the past 12 months (or for
 such shorter period that the registrant was required to file such reports),
 and (2) has  been subject to such filing requirements for the past 90 days.

      Yes [ X ]        No [   ]

      As of March 31, 2003, there were outstanding 88,100,766 shares of the
 issuer's Common Stock, par value $.001 per share.

 Transitional Small Business Disclosure Format (check one)

      Yes [   ]        No [ X ]

<PAGE>


                         AMERICAN HEALTHCHOICE, INC.

                             INDEX TO FORM 10-QSB

                     For the Quarter Ended March 31, 2003



       Part I Financial Information

         Item 1.  Financial Statements

            Consolidated Balance Sheet .....................          2

            Consolidated Statement of Operations ...........          3

            Consolidated Statement of Cash Flows ...........          4

            Notes to Consolidated Financial Statements .....          5


         Item 2.  Management's Discussion and Analysis or
                  Plan of Operation ........................          6


       Part II Other Information

         Item 1.  Legal Proceedings ........................          8

         Item 2.  Changes in Securities and Use of Proceeds           8

         Item 3.  Defaults upon Senior Securities ..........          8

         Item 4.  Submission of Matters to a Vote of
                  Security Holders .........................          8

         Item 5.  Other Information ........................          8

         Item 6.  Exhibits and Reports on Form 8-K .........          9


       Signatures and Certifications .......................         10

<PAGE>

                        PART I. FINANCIAL INFORMATION

 Item 1. Financial Statements

                         AMERICAN HEALTHCHOICE, INC.
                               AND SUBSIDIARIES

                          CONSOLIDATED BALANCE SHEET
                                 (Unaudited)
                                MARCH 31, 2003

                                   ASSETS

 Current Assets:
 Cash                                                         $     15,527
 Accounts receivable, less allowance for doubtful
   accounts of $ 7,197,980                                       5,988,763
 Other current assets                                               63,740
                                                               -----------
      Total current assets                                       6,068,030

 Property and equipment, net                                       348,691
 Goodwill, net                                                   2,348,570
 Other assets                                                       28,120
                                                               -----------
      Total assets                                            $  8,793,411
                                                               ===========

                  LIABILITIES AND STOCKHOLDERS' EQUITY

 Current Liabilities:
 Notes payable and capital lease obligation                  $     973,015
 Convertible debentures                                          1,310,400
 Bankruptcy claims                                               1,166,150
 Accrued payroll and payroll taxes                                 486,458
 Accounts payable and accrued expenses                             353,394
                                                               -----------
      Total current liabilities                                  4,289,417

 Commitments                                                             _

 Stockholders' Equity:
 Preferred stock, $.001 par value; 5,000,000 shares
   authorized; none issued                                               -
 Common stock, $.001 par value; 115,000,000 shares
   authorized; 88,100,766 shares issued and outstanding             88,100
 Options to acquire common stock                                     8,000
 Additional paid-in capital                                     20,534,684
 Accumulated deficit                                           (16,126,790)
                                                               -----------
      Total stockholders' equity                                 4,503,994
                                                               -----------
      Total liabilities and stockholders' equity              $  8,793,411
                                                               ===========


      See accompanying notes to these consolidated financial statements.

<PAGE>
<TABLE>

                          AMERICAN HEALTHCHOICE, INC.
                                AND SUBSIDIARIES

                     CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (Unaudited)



                                    Three Months Ended March 31,       Six Months Ended March 31,
                                    ----------------------------       ---------------------------
                                       2002             2003              2002             2003
                                    ----------       ----------        ----------       ----------
 <S>                               <C>              <C>               <C>              <C>
 Revenues:
   Patient billings                $ 2,157,269      $ 1,821,046       $ 3,989,448      $ 3,925,116
   Allowance for discount
   on billings                         863,577          808,293         1,531,055        1,737,818
                                    ----------       ----------        ----------       ----------
     Net revenues                    1,293,692        1,012,753         2,458,393        2,187,298

 Operating Expenses:
   Compensation and benefits           701,920          683,835         1,428,034        1,352,350
   Depreciation and amortization        42,807            7,782            85,944           15,564
   General and administrative          422,162          395,851           787,690          778,009
   Rent                                100,608           81,271           195,570          176,708
                                    ----------       ----------        ----------       ----------
     Total operating expenses        1,267,497        1,168,739         2,497,238        2,322,631

   Interest expense and other
     costs of borrowing                (20,296)         (15,342)          (40,584)         (34,846)
                                    ----------       ----------        ----------       ----------
 Net Income (Loss)                 $     5,899      $  (171,328)      $   (79,429)     $  (170,179)
                                    ==========       ==========        ==========       ==========

 Basic and Diluted Net Income
   (Loss) Per Share                $         -      $         -       $         -      $         -


 Weighted Average Common Shares
   Outstanding                      93,825,766       88,100,766        93,825,766       88,100,766



      See accompanying notes to these consolidated financial statements.

</TABLE>
<PAGE>

                         AMERICAN HEALTHCHOICE, INC.
                               AND SUBSIDIARIES

                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (Unaudited)


                                                    Six Months Ended March 31,
                                                    --------------------------
                                                        2002         2003
                                                      ---------    ---------
 Cash Flows From Operating Activities:
 Net loss                                            $  (79,429)  $ (170,179)
 Adjustments to reconcile net loss to net cash
   provided by (used in) operating activities:
   Allowance for doubtful accounts                    1,531,055    1,737,818
   Employee compensation-stock                           43,800       24,000
   Depreciation and amortization                         85,944       15,564
 Change in operating assets and liabilities, net:
   Accounts receivable-trade                         (1,662,161)  (1,617,333)
   Other current assets                                 (33,981)      (4,396)
   Accounts payable and accrued expenses                 56,938       17,257
                                                      ---------    ---------
        Net cash provided by (used in)
          operating activities                          (57,834)       2,731

 Cash Flows From Investing Activities:
   Property and equipment                               (15,061)     (53,559)
                                                      ---------    ---------
        Net cash used in investing activities           (15,061)     (53,559)

 Cash Flows From Financing Activities:
   Proceeds from notes payable                           65,715       55,859
   Payments on notes payable and capital leases          (9,244)        (800)
                                                      ---------    ---------
        Net cash provided by financing activities        56,471       55,059
                                                      ---------    ---------
 Net Increase (Decrease) In Cash                        (16,424)       4,231
 Cash At Beginning Of Year                               37,303       11,296
                                                      ---------    ---------
 Cash At End Of Period                               $   20,879   $   15,527
                                                      =========    =========


 Supplemental Disclosure Of Cash Flow Information:
   Income taxes paid                                 $      610   $    2,000
   Interest paid                                          1,600        1,000

 Supplemental Disclosure of Non-Cash Transactions:
   Offset reduction in valuation of clinic assets
     acquired against goodwill                          330,000            -


     See accompanying notes to these consolidated financial statements.

<PAGE>

                         AMERICAN HEALTHCHOICE, INC.
                               AND SUBSIDIARIES

                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 1.   Organization

 American HealthChoice, Inc.  and subsidiaries  (the Company)  consists of  a
 parent company and thirteen clinics providing medical, physical therapy, and
 chiropractic services in  San Antonio, McAllen,  Laredo, San Benito,  Corpus
 Christi and Houston, Texas, and New  Orleans, Louisiana.  Substantially  all
 of the Company's  revenues are derived  from chiropractic, physical  therapy
 and medical services provided to individuals  living in the vicinity of  the
 clinics.


 2.   Basis of Presentation

 The accompanying unaudited interim consolidated financial statements of  the
 Company  have  been  prepared  pursuant  to  the  rules  and  regulations of
 the Securities  and Exchange Commission.  Certain  information  in  footnote
 disclosures normally included in financial statements prepared in accordance
 with generally accepted accounting principles have been condensed or omitted
 pursuant to these rules and regulations. The accompanying unaudited  interim
 consolidated financial statements reflect all adjustments which the  Company
 considers necessary for a fair presentation of the results of operations for
 the interim periods covered and for  the financial condition of the  Company
 at the date of the interim balance  sheet.  All such adjustments (except  as
 otherwise disclosed herein) are of a normal recurring nature.

 The results of operations for  the six months ended  March 31, 2003 are  not
 necessarily indicative of the results to be expected for the full year.   It
 is suggested  that the  March  31, 2003  financial  information be  read  in
 conjunction with the financial statements and notes thereto included in  the
 Company's Form 10-KSB dated September 30, 2002.


 3.   Summary of Significant Accounting Policies

 Consolidation policy  - The  accompanying condensed  consolidated  financial
 statements  include  the  accounts  of  the  Company  and  its  wholly-owned
 subsidiaries.   All material  inter-company accounts  and transactions  have
 been eliminated in consolidation.

 Net patient revenues - Revenue is  recognized upon performance of  services.
 Substantially all  of  the  Company's  revenues  are  derived  from  patient
 insurance settlements,  claims filed  on  major medical  policies,  worker's
 compensation policies, Medicare, and Medicaid.  Allowances for discounts  on
 services provided  are recognized  in the  periods  the related  revenue  is
 earned.   Allowances  are maintained  at  levels considered  appropriate  by
 management based  upon historical  charge-off experience  and other  factors
 deemed pertinent by  management.  The  Company has no  contracts with  third
 party payors that would require the disclosure of the amount of  contractual
 adjustments.

 Property and equipment, net - Property and equipment are stated at cost less
 accumulated  depreciation.  Depreciation  is  provided  over  the  estimated
 useful lives  of  the  related assets,  primarily  using  the  straight-line
 method.  Leasehold improvements are amortized over the shorter of the  lease
 term or the estimated useful lives of the improvements.

 Goodwill -  The  Company  elected  to  adopt  the  provisions  of  Financial
 Accounting Standard ("FAS") 142, "Goodwill  and Other Intangible Assets"  as
 of October  1, 2001.   This  policy requires  an impairment  test, which  is
 performed by the Company on an annual basis.

 Earnings per  share  - Basic  earnings  per  share are  computed  using  the
 weighted-average number of common shares outstanding.  Diluted earnings  per
 share are  computed using  the  weighted-average common  shares  outstanding
 after giving effect to  potential common stock from  stock options based  on
 the treasury  stock  method,  plus  other  potentially  dilutive  securities
 outstanding.  If the result of assumed conversions is dilutive, net earnings
 are adjusted for  the interest expense  on the convertible  debt, while  the
 average shares of common stock outstanding are increased.

 4.   Goodwill

 The Company elected to adopt the provisions of Financial Accounting Standard
 ("FAS") 142, "Goodwill and Other Intangible  Assets" as of October 1,  2001.
 This pronouncement addresses  the issue of  proper accounting and  reporting
 for intangible assets,  such as purchased  goodwill.  FAS  142 modified  the
 purchase method of  accounting by eliminating  the amortization of  goodwill
 and substituting an impairment  test.  For  testing purposes the  "reporting
 unit", as prescribed by FAS 142, is the three clinics acquired in  September
 2000 for a total purchase price of $6,000,000.

 For the twelve month period ended  September 30, 2002, operating income  for
 the reporting unit was  $163,000 compared to $927,000  for the twelve  month
 period ended  September  30,  2001.   Due  to  the  substantial  decline  in
 operating income,  the  Company engaged  an  independent valuation  firm  to
 conduct the impairment test as of September  30, 2002.  Based on the  income
 approach, in the opinion of the  independent valuation firm, the fair  value
 of the net assets of the reporting unit was $4,000,000.  Since the  carrying
 value of  the  reporting  unit was  approximately  $4,900,000,  the  Company
 elected to record an impairment loss of $900,000.

 The primary assumption used for the income approach was an average operating
 income of approximately $400,000 per year for the five years commencing with
 the fiscal year ending September 30, 2003.  Operating income for these three
 clinics for the first six months of fiscal 2003 was $36,000.  Management has
 taken  steps  to  increase  patient  billings  at  these  three  clinics  by
 increasing the  number  of  new patients  and  concurrently  increasing  the
 average billing  per case.   Based  on this  projected increase  in  patient
 billings and already implemented reductions in operating expenses, the three
 clinics should recognize operating income  of approximately $200,000 in  the
 second half of fiscal  2003.  Management believes  that the reporting   unit
 should achieve operating  income of  approximately $400,000  in fiscal  year
 2004 and subsequent years.  Therefore,  recognition of a further  impairment
 to the carrying value of the reporting unit is not required at this time.


 Item 2.   Management's Discussion and Analysis or Plan of Operation

 Results of Operations

 The following discussion and analysis should be read in conjunction with the
 Consolidated Financial Statements and Notes thereto, and is qualified in its
 entirety by the foregoing and by  other more detailed financial  information
 appearing elsewhere.

 Three Months Ended March 31, 2003  Compared to Three Months Ended March  31,
 2002

      Patient Billings.  For the three  months ended March 31, 2003,  patient
 billings decreased  from $2,157,000  in 2002  to  $1,821,000  in  2003.  The
 decrease is primarily  attributable to a  decrease in  patient billings  for
 personal injury cases in the San  Antonio clinics of approximately  $160,000
 and a decrease  in patient billings  for the clinics  acquired in  September
 2000 in the amount of $150,000.

      Allowance for Discount on Billings.   For the three months ended  March
 31, 2003, allowance for discount on billings decreased from $864,000 for the
 same period in 2002 to  $808,000 in 2003.   The decrease is attributable  to
 the decrease  in patient  billings offset  by an  upward adjustment  in  the
 allowance as a percentage of patient billings from 40% in the 2002 period to
 44% in the 2003 period.  The  adjustment reflects an increase in the  number
 of new personal injury cases written off in the 2003 period due primarily to
 the absence of insurance coverage.  The collection percentage on cases  that
 were settled by patient's attorneys in 2003 was comparable to 2002.

      Compensation and Benefits.  For the three months ended March 31,  2003,
 compensation and benefits  decreased from $702,000  in 2002  to $684,000  in
 2003.  The decrease is primarily attributable to personnel reductions at the
 corporate office in the amount of  $24,000.  The number of clinic  employees
 was unchanged in the 2003 period compared to the same period in 2002.

      Depreciation and Amortization.   For the three  months ended March  31,
 2003, depreciation and amortization decreased from $43,000 in 2002 to $8,000
 in 2003.  The decrease was primarily due to amortization of financing  costs
 in the  amount of  $22,000 in  the 2002  period.   The  2003 period  has  no
 amortization of  financing costs  since the  costs were  amortized in  prior
 years.

      General and Administrative.  For the three months ended March 31, 2003,
 general and administrative decreased  from $422,000 in  2002 to $396,000  in
 2003. Marketing and advertising expenses  in the Texas chiropractic  clinics
 decreased by approximately $25,000 due to  a reduction in the number of  new
 patients.   Other  expense categories  were  unchanged in  the  2003  period
 compared to the same period in 2002.

      Rent.  For  the three  months ended March  31, 2003,  rent was  $81,000
 compared  to  $101,000  in  the  2002  period.  The  decrease  is  primarily
 attributable to  the  Company  moving its  corporate  office  to  a  smaller
 location at the end of January 2003.  The monthly savings are  approximately
 $6,000 per month, which reduced rent expense for the 2003 period by $12,000.


 Six Months Ended March 31, 2003 Compared to Six Months Ended March 31, 2002

      Patient Billings.   For the six  months ended March  31, 2003,  patient
 billings decreased  from $3,989,000  in 2002  to  $3,925,000  in  2003.  The
 decrease is attributable to a decrease  in patient billings for the  clinics
 acquired in September 2000 in the  amount of $380,000 offset by an  increase
 in patient billings for personal injury cases in the San Antonio and Houston
 clinics of approximately $290,000.

      Allowance for Discount on Billings.  For the six months ended March 31,
 2003, allowance for discount on billings  increased from $1,531,000 for  the
 same period in 2002 to $1,738,000 in 2003.  The increase is attributable  to
 an upward adjustment in  the allowance as a  percentage of patient  billings
 from 38% in  the 2002  period to 44%  in the  2003 period.   The  adjustment
 reflects an increase in the number of new personal injury cases written  off
 in the 2003 period due primarily to the absence of insurance coverage.   The
 collection percentage on cases that were  settled by patient's attorneys  in
 2003 was comparable to 2002.

      Compensation and Benefits.   For the six months  ended March 31,  2003,
 compensation and benefits decreased from $1,428,000 in 2002 to $1,352,000 in
 2003.  The decrease is attributable  to personnel reductions at the  clinics
 and corporate office, which  reduced 2003 expense in  the amount of  $24,000
 and $53,000, respectively.

      Depreciation and  Amortization.   For the  six months  ended March  31,
 2003, depreciation  and  amortization  decreased from  $86,000  in  2002  to
 $16,000  in  2003.  The  decrease  was  primarily  due  to  amortization  of
 financing costs in  the amount  of $44,000  in the  2002 period.   The  2003
 period has no amortization of financing costs since the costs were amortized
 in prior years.

      General and Administrative.  For the  six months ended March 31,  2003,
 general and administrative decreased  from $788,000 in  2002 to $778,000  in
 2003.  There were  no material changes in  major expense categories in  2003
 compared to the same period in 2002.

      Rent.   For the  six months  ended March  31, 2003,  rent was  $177,000
 compared  to  $196,000  in  the  2002  period.  The  decrease  is  primarily
 attributable to  the  Company  moving its  corporate  office  to  a  smaller
 location at the end of January 2003.  The monthly savings are  approximately
 $6,000 per month, which reduced rent expense for the 2003 period by $12,000.


 Liquidity and Capital Resources

 For the six  months ended  March 31, 2003,  net cash  provided by  operating
 activities was $3,000 compared to net  cash used in operating activities  in
 the amount of $58,000 for the six months  ended March 31, 2002.  There  were
 no significant differences in the 2003  period compared to the 2002  period.
 Capital expenditures were financed by proceeds from notes payable.

 During the year ended September 30, 2002, cash generated from operations was
 sufficient to  meet  current  obligations  including  capital  expenditures.
 However, funds were not available to satisfy bankruptcy plan payments due in
 September 2001 and September  2002.  At September  30, 2002 the Company  was
 delinquent on payments due to unsecured  creditor claims and insider  claims
 in the amounts  of $356,000 and  $440,000, respectively.   In addition,  the
 loan in the amount of $837,000 issued in connection with the acquisition  of
 three clinics in September  2000 was due and  payable on September 1,  2002.
 The amount past due including unpaid interest is approximately $987,000.

 In the  case of  the bankruptcy  payments, fewer  than five  creditors  have
 pursued collection of claims due as of September 30, 2002.  The Company  was
 able to meet  these payments and  avoid legal action  on the  part of  these
 creditors.  At the present time, Management does not foresee any  individual
 creditors initiating legal action in regards to past due payment of  claims.
 However, there are  no assurances that  an individual creditor  or group  of
 creditors will  not  pursue  legal action  which  could  result  in  adverse
 consequences to the Company.

 For the six months ended March 31, 2003, collections of patient billings was
 $2,336,000 compared to $1,883,000 for the  six months ended March 31,  2002.
 As a result,  the Company was  able to meet  obligations for  the first  six
 months of  the current  fiscal  year.   However,  patient billings,  net  of
 allowance  for  discounts,  declined  from  $2,458,000  to   $1,883,000  for
 the  comparable  periods,  respectively.  Net  revenues  must  increase   to
 approximately $400,000 per month for the Company to meet its obligations  in
 the future.   In this regard,  Management continues to  focus on  increasing
 payments on  personal injury  case settlements  and increase  the number  of
 worker's compensation cases, which result  in higher settlement amounts  per
 case compared to personal injury cases.   In addition, efforts are  underway
 to reduce marketing costs at the San Antonio clinics.  As a result of  these
 and other actions  to improve cash  flow, overall  liquidity should  improve
 during the second six months of fiscal 2003.

 Before June 30, 2003, Management expects to amend the note payable issued in
 connection with the acquisition of three clinics to allow for payment over a
 longer period of time.

 Forward-Looking Information

 This report  contains  certain forward-looking  statements  and  information
 relating to  the Company  that are  based on  the beliefs  of the  Company's
 management  as  well  as  assumptions  made  by  and  information  currently
 available to the Company's management. When  used in the report, words  such
 as "anticipate," "believe,"  "estimate," "expect,"  "intend," "should,"  and
 similar expressions,  as  they relate  to  the Company  or  its  management,
 identify forward-looking statements.   Such statements  reflect the  current
 views of  the Company  with respect  to  future events  and are  subject  to
 certain risks, uncertainties,  and assumptions relating  to the  operations,
 results of  operations,  liquidity,  and growth  strategy  of  the  Company,
 including competitive factors  and pricing pressures,  changes in legal  and
 regulatory requirements, interest  rate fluctuations,  and general  economic
 conditions, as well as other factors  described in this report.  Should  one
 or more of  the risks materialize,  or should  underlying assumptions  prove
 incorrect, actual  results  or  outcomes  may  vary  materially  from  those
 described herein as anticipated, believed, estimated, expected, or intended.


                         Part II.  OTHER INFORMATION

 Item 1.  Legal Proceedings

 There have been no material events  related to legal proceedings during  the
 quarter ended March 31, 2003 and there have been no material events  related
 to legal proceedings reported  in the Registrants  10-KSB filed January  14,
 2003.


 Item 2.  Changes in Securities and Use of Proceeds

 Not applicable


 Item 3.  Defaults upon Senior Securities

 None to report


 Item 4.   Submission of matters to a vote of security holders

 None to report


 Item 5.  Other Information

 None


 Item 6.  Exhibits and Reports on Form 8-K

 99.1      Certification pursuant to 18 U.S.C. Section 1350, as adopted
           pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for
           Dr. J. W. Stucki, President and Chief Executive Officer.

 99.2      Certification pursuant to 18 U.S.C. Section 1350, as adopted
           pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for
           John C. Stuecheli, Vice President and Chief Financial Officer.

 No Form 8-K Reports were filed during the quarter ended March 31, 2003.


                               SIGNATURES

      In accordance with Section 13 or  15(d) of the Securities Exchange  Act
 of 1934, the Registrant caused this Report to be signed on its behalf by the
 undersigned, thereunto duly authorized.



                               AMERICAN HEALTHCHOICE, INC.

 Date: May 15, 2003            By:  /s/ Dr. J.W. Stucki
                               Dr. J.W. Stucki, Chief Executive
                               Officer and President

 Date: May 15, 2003            By:  /s/John C. Stuecheli
                               John C. Stuecheli, Chief Financial
                               Officer and Vice President - Finance
                               (Principal Financial and Accounting Officer)


<PAGE>

                               CERTIFICATIONS


        I, Dr. J. W. Stucki, Chief Executive Officer and President, certify
 that:

   1. I have reviewed this quarterly report on Form 10-QSB of American
      HealthChoice, Inc.;

   2. Based on my knowledge, this quarterly report does not contain any
      untrue statement of a material fact or omit to state a material fact
      necessary to make the statements made, in light of the circumstances
      under which such statements were made, not misleading with respect to
      the period covered by this quarterly report;

   3. Based on my knowledge, the financial statements, and other financial
      information included in this quarterly report, fairly present in all
      material respects the financial condition, results of operations and
      cash flows of the registrant as of, and for, the periods presented in
      this quarterly report;

   4. The registrant's other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant
      and we have:

        a) Designed such disclosure controls and procedures to ensure that
           material information relating to the registrant, including its
           consolidated subsidiaries, is made know to us by others within
           those entities, particularly during the period in which this
           quarterly report is being prepared;

        b) Evaluated the effectiveness of the registrant's disclosure
           controls and procedures as of a date within 90 days prior to the
           filing date of this quarterly report for the three months ended
           March 31, 2003 (the "Evaluation Date"); and

        c) Presented in this quarterly report our conclusions about the
           effectiveness of the disclosure controls and procedures based on
           our evaluation as of the Evaluation Date;

   5. The registrants other certifying officer and I have disclosed, based
      on our most recent evaluation, to the registrant's auditors and the
      audit committee of registrant's board of directors:

        a) All significant deficiencies in the design or operation of
           internal controls which could adversely affect the registrant's
           ability to record, process, summarize and report financial data
           and have identified for the registrant's auditors any material
           weaknesses in internal controls; and

        b) Any fraud, whether or not material, that involves management or
           other employees who have a significant role in the registrant's
           internal controls; and

   6. The registrant's other certifying officer and I have indicated in this
      quarterly report whether or not there were significant changes in
      internal controls or in other factors that could significantly affect
      internal controls subsequent to the date of our most recent evaluation,
      including any corrective actions with regard to significant
      deficiencies and material weaknesses.


 /s/ Dr. J. W. Stucki

 Dr. J. W. Stucki
 Chief Executive Officer and President

 May 15, 2003

<PAGE>
                               CERTIFICATIONS


 I, John C. Stuecheli, Chief Financial Officer and Vice President-Finance,
 certify that:

   1. I have reviewed this quarterly report on Form 10-QSB of American
      HealthChoice, Inc.;

   2. Based on my knowledge, this quarterly report does not contain any
      untrue statement of a material fact or omit to state a material fact
      necessary to make the statements made, in light of the circumstances
      under which such statements were made, not misleading with respect to
      the period covered by this quarterly report;

   3. Based on my knowledge, the financial statements, and other financial
      information included in this quarterly report, fairly present in all
      material respects the financial condition, results of operations and
      cash flows of the registrant as of, and for, the periods presented in
      this quarterly report;

   4. The registrant's other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant
      and we have:

        a. Designed such disclosure controls and procedures to ensure that
           material information relating to the registrant, including its
           consolidated subsidiaries, is made know to us by others within
           those entities, particularly during the period in which this
           quarterly report is being prepared;

        b. Evaluated the effectiveness of the registrant's disclosure
           controls and procedures as of a date within 90 days prior to the
           filing date of this quarterly report for the three months ended
           March 31, 2003 (the "Evaluation Date"); and

        c. Presented in this quarterly report our conclusions about the
           effectiveness of the disclosure controls and procedures based on
           our evaluation as of the Evaluation Date;

   5. The registrants other certifying officer and I have disclosed, based
      on our most recent evaluation, to the registrant's auditors and the
      audit committee of registrant's board of directors:

        a. All significant deficiencies in the design or operation of
           internal controls which could adversely affect the registrant's
           ability to record, process, summarize and report financial data
           and have identified for the registrant's auditors any material
           weaknesses in internal controls; and

        b. Any fraud, whether or not material, that involves management or
           other employees who have a significant role in the registrant's
           internal controls; and

   6. The registrant's other certifying officer and I have indicated in this
      quarterly report whether or not there were significant changes in
      internal controls or in other factors that could significantly affect
      internal controls subsequent to the date of our most recent evaluation,
      including any corrective actions with regard to significant
      deficiencies and material weaknesses.


 /s/ John C. Stuecheli

 John C. Stuecheli
 Chief Financial Officer and Vice President-Finance

 May 15, 2003